About: Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1998 (uk) im November 1998 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1998 (en) artículu científicu espublizáu en payares de 1998 (ast)
publication date	wds:Q77407534-4F8B0710-D09D-497B-B8C2-78E4AE04F2A3
publication date	1998-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q77407534-2DE8759C-095F-449C-A3F1-5C0AB606969D wds:Q77407534-430C8326-D14B-4EF6-9DDA-310B78CB0A6E wds:Q77407534-54EA87D5-B8A0-4FFA-9EFF-2F9010E4FA69 wds:Q77407534-5F28D339-69E0-4832-A3BA-37D1E2F907F8 wds:Q77407534-93C28FD9-DF7A-4D9E-9079-24AA7E76E177 wds:Q77407534-A0F2EB3F-1CF9-4ED4-BFC5-56A149416B4C wds:Q77407534-A4FF49F4-B6DF-41D7-94B9-AADF8C419362 wds:Q77407534-A9A85F78-7CE4-48BA-A1F2-9CBF778BC3DA wds:Q77407534-ABA88091-7CBD-48B7-8A44-F4D54F6A3065
author name string	M Osame I Kitajima I Maruyama K Matsuo K Arimura O Watanabe M Hanatani H Arimura T Arisato
rdfs:label	Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome (en) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (nl)
skos:prefLabel	Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome (en) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (nl)
name	Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome (en) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (nl)
title	wds:Q77407534-12AEF363-D728-445D-B6B0-3AC6745CC226
title	Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome (en)
page(s)	wds:Q77407534-0A106636-B17F-42C5-B286-B25910A56169
page(s)	1390-1397
instance of	wds:Q77407534-DA5BD3B4-846D-47B2-97FF-737E96C04F1D
instance of	scholarly article
main subject	wds:Q77407534-3916255D-7DBC-4AAB-B40D-DC5C2D68932A
main subject	POEMS syndrome
PubMed ID	wds:Q77407534-6663CA00-83CB-40DB-98C6-2680D4C4E7FD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9771661
PubMed ID	9771661
published in	wds:Q77407534-249850CE-A7F2-4CB1-B857-2D60E920A3BA
published in	Muscle and Nerve
issue	wds:Q77407534-7E38E11D-47C3-45DE-B325-4A50A6329F1D
volume	wds:Q77407534-33E467AA-CC5E-43D2-B378-50BCA50F78CF
issue	11
volume	21
DOI	wds:Q77407534-A4FDE4DC-3A16-4AA5-BBDD-882E6FECA184
DOI	http://dx.doi.org/10.1002/(SICI)1097-4598(199811)21:11%3C1390::AID-MUS5%3E3.0.CO;2-4
DOI	10.1002/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77407534
is cites work of	Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype Peripheral nervous system involvement in patients with cancer Pulmonary hypertension in POEMS syndrome Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome POEMS syndrome with severe neurological damage clinically recovered with lenalidomide Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome Treatment of POEMS syndrome Atypical B12 deficiency with nonresolving paraesthesia Expression of vascular endothelial growth factor in tuberculous meningitis. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome How I treat POEMS syndrome Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation Intracranial hemangiomas in a patient with POEMS syndrome. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities Chronic inflammatory demyelinating polyneuropathy Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report Expression of vascular endothelial growth factor by plasma cells in the sclerotic bone lesion of a patient with POEMS syndrome Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study Plexogenic pulmonary hypertension associated with POEMS syndrome. Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome Nerve pathologic features differentiate POEMS syndrome from CIDP. POEMS syndrome complicated by extensive arterial thromboses. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome. Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue. Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure Young patient with arterial thrombosis and skin changes as the onset manifestations: POEMS syndrome Immunological mechanisms in paraneoplastic peripheral neuropathy Alcohol Misuse Link to POEMS Syndrome in a Patient [POEMS syndrome (or Crow-Fukase syndrome)] Two causes of demyelinating neuropathy in one patient: CMT1A and POEMS syndrome An update on the diagnosis and management of the polyneuropathy of POEMS syndrome Multicentric, Hyaline Vascular Variant of Castleman's Syndrome An unusual case of myocardial infarction Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome Advances in the Treatment of Paraproteinemic Neuropathy. Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome. POEMS SYNDROME: an Update POEMS Syndrome Diagnosed 10 Years after Disabling Peripheral Neuropathy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software